L26/P-361 Endometrial CD138 immunostaining and absolute bacterial quantification provide complementary information for chronic endometritis management
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Nishii und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does CD138-positive endometrial inflammation reflect bacterial presence, and do CD138 immunostaining and qPCR-based bacterial quantification provide complementary information for chronic endometritis management? Summary answer Most CD138-positive cases showed no detectable bacteria (76%), with associations confined to chronic endometritis–reported pathogens rather than dysbiosis-related bacteria. What is known already Chronic endometritis (CE) is diagnosed by CD138-positive plasma cell infiltration and commonly treated with broad-spectrum antibiotics, assuming bacterial infection contributes to most cases, partly because the uterine cavity is a low-biomass environment where bacterial culture is often unsuccessful. Most microbiome studies rely on next-generation sequencing, which provides relative abundance rather than absolute bacterial load. This limitation has yielded inconsistent findings regarding the relationship between bacterial presence and CD138-positive inflammation. Whether CD138 positivity reflects active bacterial involvement warranting antibiotic treatment, or non-infectious inflammatory processes requiring different management, remains unclear. Direct evaluations comparing qPCR-based absolute bacterial quantification with CD138 status are limited. Study design, size, duration This retrospective cohort study included 97 infertile women who underwent endometrial assessment at a single IVF center between April and December 2025. Endometrial biopsies for CD138 immunostaining and qPCR-based microbial analysis were collected simultaneously during the secretory phase of the menstrual cycle. The primary objective was to evaluate differential associations between CD138-positive inflammation and two bacterial categories. Participants/materials, setting, methods CE was diagnosed by the McQueen classification (≥1 CD138-positive plasma cell per high-power field). qPCR targeted 26 bacterial species classified into: (1) 10 CE-reported pathogenic bacteria and (2) 16 other dysbiosis-related bacteria. Bacterial positivity was defined as ≥ 1 DNA copy/mL. Associations were evaluated using Fisher’s exact test with odds ratios and 95% confidence intervals. Main results and the role of chance Among 97 infertile women, 46 (47.4%) were CD138-positive. Notably, 76.1% (35/46) of CD138-positive cases showed no detectable bacteria by qPCR. Among CD138-positive women, chronic endometritis-reported pathogenic bacteria were detected in 11 cases (23.9%), whereas dysbiosis-related bacteria were detected in 14 cases (30.4%). In contrast, among CD138-negative women (n = 51), pathogenic bacteria were detected in only 2 cases (3.9%), while dysbiosis-related bacteria were detected in 17 cases (33.3%). CD138 positivity was significantly associated with presence of pathogenic bacteria (p = 0.0058; odds ratio [OR] 7.70, 95% confidence interval [CI] 1.61–36.93). No significant association was observed between CD138 positivity and dysbiosis-related bacteria (p = 0.157; OR 0.46, 95% CI 0.18–1.21). These findings indicate CD138-positive inflammation is preferentially associated with a limited subset of CE-reported pathogens rather than with dysbiosis-related bacteria. The high proportion of bacteria-negative CD138-positive cases suggests CD138-defined inflammation frequently occurs in absence of detectable microbial burden, supporting interpretation that CD138 reflects inflammatory status rather than overall bacterial presence. Limitations, reasons for caution This retrospective study had limited sample size. The qPCR panel targeted predefined bacterial species and may not capture rare or unknown pathogens. The cross-sectional design precludes causal inference. This study included all CD138-positive cases regardless of severity; the relationship in severe cases warranting antibiotic treatment was not specifically evaluated. Wider implications of the findings These findings support viewing CD138 immunostaining and qPCR-based quantification as complementary diagnostic approaches. The high proportion of bacteria-negative CD138-positive cases supports reconsideration of uniform antibiotic treatment. Conversely, pathogenic bacteria were detected in some CD138-negative patients. Inflammatory status and microbial burden should be evaluated separately and integrated for individualized treatment planning. Trial registration number Yes
Zitieren
APA
Nishii, S., Iwami, N., Kamiya, H., & Kawai, K. (2026). L26/P-361 Endometrial CD138 immunostaining and absolute bacterial quantification provide complementary information for chronic endometritis management. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.696
Vancouver
Nishii S, Iwami N, Kamiya H, Kawai K. L26/P-361 Endometrial CD138 immunostaining and absolute bacterial quantification provide complementary information for chronic endometritis management. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.696
BibTeX
@article{Nishii2026,
author = {Nishii, S. and Iwami, N. and Kamiya, H. and Kawai, K.},
title = {L26/P-361 Endometrial CD138 immunostaining and absolute bacterial quantification provide complementary information for chronic endometritis management},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.696}
}
EUVIMED